ARCHIVES

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

DCBDC Advisors Okay New Program In Breast Cancer

July 3, 1992

HHS Names Crawford FDA Deputy Commissioner; Williams Appointed Deputy For Oncology Division.

March 1, 2002

NCI RFP Available.

February 18, 2000

Wisconsin Group Takes Lead In Challenging Pain Control Perception

April 21, 1989

Six Compounds Carcinogenic, Risk to Humans, CH Subgroup Finds

February 2, 1979

Adding Ultrasound Revealed More Breast Cancers In Study

May 30, 2008